Canadian Sec - Delayed Quote CAD
Pharmala Biotech Holdings Inc. (MDMA.CN)
At close: October 18 at 3:38 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Nicholas Kadysh | Director, Pres and Chief Exec. Officer | -- | -- | -- |
| Mr. Carmelo Marrelli ACIS, B.Comm., C.A., CGA, CPA | Chief Financial Officer and Corp. Sec. | -- | -- | 1971 |
| Dr. Shane Morris Ph.D. | Chief Operating Officer | -- | -- | 1975 |
| Mr. David Purcell | Director of Sales | -- | -- | -- |
Pharmala Biotech Holdings Inc.
1111 Melville Street
Suite 1100
Vancouver, BC V6E 3V6
Canada
- Sector:?
- Healthcare
- Industry:? Biotechnology
Description
Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.
Corporate Governance
Pharmala Biotech Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
PHRM.CN PharmaTher Holdings Ltd.
0.2900
+23.40%
CYBN.NE Cybin Inc.
15.70
+9.64%
DRUG.CN Bright Minds Biosciences Inc.
102.72
+242.40%
MSCL.TO Satellos Bioscience Inc.
0.8000
+17.65%
PHRRF PharmaTher Holdings Ltd.
0.2080
+4.00%
HEM.V Hemostemix Inc.
0.0900
+12.50%
BIOV.CN BioVaxys Technology Corp.
0.0500
0.00%
XRTX.V XORTX Therapeutics Inc.
2.6900
+0.75%
CYBN Cybin Inc.
11.41
+9.19%
ARCH.V Arch Biopartners Inc.
2.1400
+7.00%